Signet ring cell prostate cancer (SRCC) is a rare histotype of neoplasm occurring in less than 2,5% of all prostatic tumors. It is actually considered as an aggressive variant of high-grade prostatic adenocarcinoma with poor prognosis and limited life expectancy. Because of his rarity, data in the literature are limited and no recommended treatments have been established to date. We report the case of a signet-ring cell prostate cancer treated with a combination of external beam radiotherapy and total androgen blockade.
Signet ring cell prostate carcinoma: an aggressive histologic variant / Olivieri, Valerio; Fortunati, Valentina; Pezzuto, Valter; DE LUCA, Francesco; Maurizi, Angela; Corongiu, Emanuele; Forte, Flavio; Annoscia, Scipio. - (2019). (Intervento presentato al convegno XXIX Cogresso Nazionale SIUrO tenutosi a Bologna).
Signet ring cell prostate carcinoma: an aggressive histologic variant
Olivieri ValerioPrimo
;De Luca Francesco;Maurizi Angela;Corongiu Emanuele;Forte FlavioPenultimo
;
2019
Abstract
Signet ring cell prostate cancer (SRCC) is a rare histotype of neoplasm occurring in less than 2,5% of all prostatic tumors. It is actually considered as an aggressive variant of high-grade prostatic adenocarcinoma with poor prognosis and limited life expectancy. Because of his rarity, data in the literature are limited and no recommended treatments have been established to date. We report the case of a signet-ring cell prostate cancer treated with a combination of external beam radiotherapy and total androgen blockade.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
